RxDoctor Payments Data

Bruce Durham, MD

Family Medicine · Hartford, KYNPI 1801116769

Payments from drug & device makers

$459in general payments, 2019–2025

Across 29 payments — averaging $15.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$98
  • AbbVie$79
  • Amgen$50
  • AstraZeneca$47
  • Phathom Pharmaceuticals, Inc.$43
  • Lilly USA, LLC$41
  • plus $100 from 5 others

What the payments were for

  • Food & beverage$459100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$459 in reported general payments places this provider in the 40th percentile of 1,559 family medicine providers in Kentucky.

See all family medicine providers in Kentucky

Medicare billing

Part B allowed, 2024
$43,791
Medicare patients
147
Services billed
658

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide58$59,005
MounjaroTirzepatide51$57,132
JanuviaSitagliptin Phosphate53$51,231
JardianceEmpagliflozin68$43,361
XareltoRivaroxaban89$39,020
EliquisApixaban72$34,587
NuplazidPimavanserin Tartrate13$32,418
FarxigaDapagliflozin Propanediol46$31,749
Trelegy ElliptaFluticasone/Umeclidin/Vilanter20$21,700
TrulicityDulaglutide11$11,986
SymbicortBudesonide/Formoterol Fumarate43$11,164
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog60$9,759
MyrbetriqMirabegron21$8,866
Lantus SolostarInsulin Glargine,hum.Rec.Anlog78$8,601
TrulancePlecanatide13$7,865

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$41$69,11862 claims
Novo NordiskOzempic$98$59,00558 claims
AstraZenecaFarxiga, Symbicort, Brilinta$47$49,376104 claims
PfizerEliquis, Dilantin$30$36,518101 claims
Astellas Pharma US IncMyrbetriq$12$8,86621 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 1,559 family medicine providers in Kentucky.

Other family medicine in Hartford

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →